Some Key Factors Driving the Growth of Medical Ceramics Market

According to the latest reserch report ”Medical Ceramics Market by Type of Material (Bioinert (Zirconia, Alumina), Bioactive (Hydroxyapatite, Glass Ceramics), Bioresorbable, Piezoceramics), Application (Dental, Orthopedic, Cardiovascular, Plastic Surgery), and Region - Global Forecast to 2022

The global medical ceramics market was valued at USD 12.87 Billion in 2016 and is projected to reach USD 18.45 Billion by 2022, at a CAGR of 6.6%.

The key factors driving the growth of this market are increasing research activities for the development of novel medical ceramics, growing demand for medical ceramics in plastic surgeries and wound healing applications, rising number of hip and knee replacement procedures, and increasing demand for implantable devices.

The growing healthcare industry in emerging economies, increasing research activities in medical ceramics for nanotechnology and electronic devices applications, and increasing number of free trade agreements is an opportunity for the market to grow.

Some of the key players in the medical ceramics market are CoorsTek (US), CeramTec (Germany), Kyocera (Japan), Morgan Advance Material (UK), NGK Spark Plug (Japan), DePuy Synthes (US), Know more about key industry players

Top-down and bottom-up approaches were used to validate the size of the global medical ceramics market and estimate the size of other dependent submarkets.

Various secondary sources such as associations/organisations/institutes like International Society for Ceramics in Medicine (OMICS), International Ceramic Federation (ICF), International Commission on Glass (ICG), Unified International Technical Conference on Refractories (UNITECR), American Ceramic Society, Association of American Ceramic Component Manufacturers (AACCM’s), Glass Manufacturing Industry Council (GMIC), European Ceramic Society (ECerS), German Ceramic Society (DKG), Italian Ceramic Society, French Group of Ceramics, Italian Ceramic Society, French Group of Ceramics, Southeast Asian Ceramic Society, Asian Ceramics, China Ceramic Industrial Association, China Ancient Ceramics Society, Indian Ceramic Society (InCerS), Japan Ceramic Society, Korean Ceramic Society, directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market.

Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess the dynamics of this market. Read more....

June 13, 2019
by Healthcare Market
0
2

Major Factors of Healthcare Fraud Detection Market

The overall healthcare fraud detection market is expected to grow from 2,242.7 million by 2022 from USD 504.4 million in 2016, at a CAGR of 28.9% from 2017 to 2022.Some of the major factors like large number of fraudulent activities in healthcare; increasing number of patients seeking health insurance; the prepayment review model; growing pressure of fraud, waste, and abuse on healthcare spending; and high returns on investment will help in the growth of the market. The healthcare fraud detection market is expanding with the emergence of new applications and technologies.

Healthcare fraud detection solutions are being used in applications such as insurance claims review, including post-payment review and pre-payment review, payment integrity and other applications including case management and identity management. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022.

The Report “Healthcare Fraud Detection Market by Type (Descriptive, Prescriptive), Application (Insurance Claim, Prepay, Post payment), Component (Service, Software), Delivery (On-premise, Cloud), End user (Insurance Payer, Private, Public) - Global Forecast to 2022

During this research study, major players operating in the healthcare fraud detection market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size.

Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the market. Read more about Healthcare Fraud Detection Market

Key players in the market include IBM (US), Optum (US), SAS (US), McKesson (US), SCIO (US), Verscend (US), Wipro (India), Conduent (US), Know more about key industry players........

June 13, 2019
by Healthcare Market
0
3

Sepsis Diagnostics Market by Technology, Product, Method, Test Type and End-User - Global Forecast to 2023

The Report ”Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023

The global sepsis diagnostics market was valued at USD 367.9 Million in 2017 and is expected to reach USD 613.9 Million by 2023, at a CAGR of 9.1% during the forecast period.

Factors such as rising prevalence of sepsis across the globe, increasing geriatric population, growing government initiatives for creating sepsis awareness, and high incidence of hospital-acquired infections are expected to drive the demand for sepsis diagnosis during the study period.

This report broadly segments the market into technology, product, pathogen, method, test type, end user, and region.

This research study involved the extensive usage of secondary sources, directories, and databases (such as D&B and Factiva), to identify and collect information useful for this technical, market-oriented, and financial study of the sepsis diagnostics market.

In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects. Read more.....

The major players of the market are bioMérieux (France), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), Abbott (US), Roche (Switzerland), Danaher (US), Becton, Dickinson, and Company (US), EKF Diagnostics (UK), Immunexpress (Australia), Know more about key industry players .......

June 13, 2019
by Healthcare Market
0
1

Healthcare Supply Chain Management Market: An Outlook to the Future Global Opportunities

The global healthcare supply chain management market is projected to reach USD 2.31 billion by 2022 from an estimated USD 1.41 billion in 2016, growing at a CAGR of 8.4% during the forecast period.

The Report “Healthcare Supply Chain Management Market by Component (Software (Inventory (Order and Warehouse Management), Purchasing (Suppliers, Strategic Sourcing)), Hardware (Barcode, RFID)), Delivery Mode (On-Premise, Cloud), End User - Global Forecasts to 2022

Increasing pressure faced by healthcare providers to improve operational efficiency and profitability, emergence of cloud-based solutions, adoption of the GS1 system of standards in various countries, and growing focus to curb the large-scale counterfeiting of drugs in the pharmaceutical industry are driving the growth of this market. Healthcare supply chain management is the vital practice of developing efficient supply chain methods to achieve operational efficiency and traceability while reducing operating costs without compromising quality.

During this research study, major players operating in the gas chromatography market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size.

Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the market. Read more..

The healthcare supply chain management market comprises a network of players involved in the research and product development; raw material supply; component manufacturing; distribution and sale; and post-sales services. Major players in the market are SAP (Germany), Oracle (US), Infor (US), GHX (US), McKesson (US), TECSYS (Canada)

Know more about key industry players

June 13, 2019
by Healthcare Market
0
1

Cerebrospinal Fluid Management Market Latest Trends 2019

The global cerebrospinal fluid management market was valued at USD 1.20 Billion in 2016 and is projected to reach USD 1.56 Billion by 2022, at a CAGR of 4.4%. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022.

The Report “Cerebrospinal Fluid Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) - Global Forecast to 2022

To speak to our analyst for a discussion on the above findings, click:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=160672575

Top-down and bottom-up approaches were used to validate the size of the global cerebrospinal fluid management market and estimate the size of other dependent submarkets.

Various secondary sources such as Food and Drug Administration (FDA), Hydrocephalus Association, World Health Organization (WHO), National Hydrocephalus Foundation (NHF), Pediatric Hydrocephalus Foundation (PHF), International Federation for Spina Bifida and Hydrocephalus (IFSBH), Hydrocephalus Clinical Research Network, Pacific Adult Hydrocephalus Center, Press Releases, Directories, Industry journals, Databases, and Annual Reports of the companies have been used to identify and collect information useful for the global study of cerebrospinal fluid management industry.

Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.

To know about the assumptions considered for the study, download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=160672575

The major players in the global cerebrospinal fluid management market are Medtronic plc (Ireland), Integra LifeSciences Holdings Corporation (US), B. Braun Melsungen AG (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical Incorporated (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan).

June 12, 2019
by Healthcare Market
0
2

Real World Evidence Solutions Market Forecast to 2023

The Report “Real World Evidence Solutions Market by Component (Dataset (Claims, Clinical, Pharmacy, Patient), Services), Therapeutic Area (Oncology, Cardiovascular, Immunology), End User (Pharmaceuticals, Medical Devices, Payers, Providers) - Global Forecast to 2023

The global real world evidence solutions market is valued at 612.0 million in 2017 and projected to reach USD 1,348.1 million by 2023, at a CAGR of 14.3%.

To know about the assumptions considered for the study, download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76173991

The growth of this market is majorly driven by the rising geriatric population (and the subsequent increase in the prevalence of chronic diseases), shift from volume- to value-based care, and delays in drug development (and the subsequent increase in development costs). The base year considered for the study is 2017 and the forecast period includes 2018 to 2023.

Top-down and bottom-up approaches were used to validate the size of Real World Evidence Solutions industry and estimate the size of other dependent submarkets. Various secondary sources such as directories, industry journals, databases such as D&B Hoovers, Bloomberg Business, and Factiva, and annual reports of the companies have been used to identify and collect information useful for the study of this market.

Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.

To speak to our analyst for a discussion on the above findings, click:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=76173991

The prominent players in the global real world evidence market are IQVIA (US), International Business Machines Corporation (US), ICON (Ireland), PAREXEL (US), Pharmaceutical Product Development (US), Optum (US), Cognizant (US), Oracle (US), SAS (US), Syneos Health (US), Anthem (US), Clinigen Group (UK), Palantir Technologies (UK), and Flatiron Health (US).

June 12, 2019
by Healthcare Market
0
1
Show more